Gland Pharma Limited has informed the Exchange about Schedule of meet
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gland Pharma has informed the stock exchanges about a scheduled one-on-one meeting with UTI Mutual Fund on August 19, 2025. The disclosure has been made under SEBI's Listing Obligations and Disclosure Requirements Regulations (Regulation 30). The company noted that the meeting schedule is subject to change due to any last-minute requirements from either side. This is a routine compliance filing with no operational or financial details disclosed.
This is a standard investor engagement disclosure and is not expected to materially impact the stock price. It signals continued dialogue between the company and institutional investors, which is a normal part of corporate communications.